Aiming to become the global leader in chip-scale photonic solutions by deploying Optical Interposer technology to enable the seamless integration of electronics and photonics for a broad range of vertical market applications

Free
Message: Denselight - Crunching the numbers - does it make sense?

"After the transaction, Denselight sales are gone as well as expenses. 100%? Less? How many people will stay on POET´s payroll? Is the complete product line sold together with DL?"

Hard to know what expenses will remain.  Looking at financials we see 2018 R & D costs of ~$8.7M, of which only $3.5M were in Singapore with the remainder in North America.  Surprising to me the R&D costs in the US were higher than in Singapore (where I thought the bulk of the R&D was being carried out!).  Seems significant work being done in the US. and begs the questions: by who and how many; what is being done; and, where is this being done (certainly not in Suresh's San Jose office)?

Year Ended December 31, 2018

Singapore

US

Canada

Consolidated

Revenue

 $      3,888,185

 $                -  

 $                -  

 $     3,888,185

Cost of revenue

 $      1,745,969

 $                -  

 $                -  

 $     1,745,969

Selling, marketing and administration

 $      8,252,278

 $     2,337,342

 $     1,099,584

 $   11,689,204

Research and Development

 $      3,533,994

 $     4,706,817

 $        451,993

 $     8,692,804

Impairment loss

 $         156,717

 $               -  

 $               -  

 $        156,717

Other income including interest income

-$     1,491,556

 $               -  

-$         14,234

-$    1,505,790

         

Net loss from operations before income tax recovery

 $     8,039,217

 $     7,044,159

 $     1,537,343

 $   16,620,719

 

 

 

Share
New Message
Please login to post a reply